Early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower T-cell activation levels

No abstract is available for this paper.

• Publication year

  2015

• Venue

  AIDS (London)

• Publication date

  2015-05-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/QAD.0000000000000625PMID 25730509
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Influence of the timing of antiretroviral therapy on the potential for normalization of immune status in human immunodeficiency virus 1-infected individuals.

  2015cited by this paper
• CD4+ and CD8+ T Cell Activation Are Associated with HIV DNA in Resting CD4+ T Cells

  2014cited by this paper
• HIV DNA Subspecies Persist in both Activated and Resting Memory CD4+ T Cells during Antiretroviral Therapy

  2014cited by this paper
• Rapid Seeding of the Viral Reservoir Prior to SIV Viremia in Rhesus Monkeys

  2014cited by this paper
• Long-Term Antiretroviral Treatment Initiated at Primary HIV-1 Infection Affects the Size, Composition, and Decay Kinetics of the Reservoir of HIV-1-Infected CD4 T Cells

  2014cited by this paper
• HIV-1 DNA predicts disease progression and post-treatment virological control

  2014cited by this paper
• Early initiation of antiretroviral therapy in HIV-infected adults and adolescents: a systematic review

  2014cited by this paper
• Research into a functional cure for HIV in neonates: the need for ethical foresight.

  2014cited by this paper
• Disparities in HIV transmission risk among HIV-infected black and white men who have sex with men, United States, 2009

  2014cited by this paper
• Antiretroviral-Free HIV-1 Remission and Viral Rebound After Allogeneic Stem Cell Transplantation

  2014cited by this paper
• HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy.

  2014cited by this paper
• HIV 2-long terminal repeat circular DNA is stable in primary CD4+T Cells.

  2013cited by this paper
• Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts.

  2013cited by this paper
• Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells.

  2013cited by this paper
• Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies

  2013cited by this paper
• Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study

  2013cited by this paper
• Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure.

  2013cited by this paper
• Antiretroviral therapy in early HIV infection.

  2013cited by this paper
• Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size.

  2013cited by this paper
• Lack of correlation between the size of HIV proviral DNA reservoir and the level of immune activation in HIV-infected patients with a sustained undetectable HIV viral load for 10 years.

  2013cited by this paper
• Increase in 2-long terminal repeat circles and decrease in D-dimer after raltegravir intensification in patients with treated HIV infection: a randomized, placebo-controlled trial.

  2013influential reference
• Antiretroviral Therapy Initiated During Acute HIV Infection Fails to Prevent Persistent T-Cell Activation

  2013cited by this paper
• Impact of Multi-Targeted Antiretroviral Treatment on Gut T Cell Depletion and HIV Reservoir Seeding during Acute HIV Infection

  2012cited by this paper
• Integrated HIV DNA accumulates prior to treatment while episomal HIV DNA records ongoing transmission afterwards

  2012cited by this paper
• Short-course raltegravir intensification does not increase 2 long terminal repeat episomal HIV-1 DNA in patients on effective antiretroviral therapy.

  2012cited by this paper
• Immunosenescence and HIV.

  2012cited by this paper
• HIV Reservoirs and Strategies for Eradication

  2012cited by this paper
• Impact of treatment with raltegravir during primary or chronic HIV infection on RNA decay characteristics and the HIV viral reservoir

  2011cited by this paper
• Relationship between residual plasma viremia and the size of HIV proviral DNA reservoirs in infected individuals receiving effective antiretroviral therapy.

  2011cited by this paper
• HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects

  2010influential reference
• B cells in early and chronic HIV infection: evidence for preservation of immune function associated with early initiation of antiretroviral therapy.

  2010cited by this paper
• HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation

  2009cited by this paper
• Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection

  2008cited by this paper
• HIV-1 Viral Replication below 50 Copies/ml in Patients on Antiretroviral Therapy is not associated with CD8+ T-cell Activation

  2007cited by this paper
• Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1.

  2005cited by this paper
• Early proliferation of CCR5(+) CD38(+++) antigen-specific CD4(+) Th1 effector cells during primary HIV-1 infection.

  2005cited by this paper
• In Vivo Evidence for Instability of Episomal Human Immunodeficiency Virus Type 1 cDNA

  2005cited by this paper
• Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells

  2003cited by this paper
• New Real-Time Reverse Transcriptase-Initiated PCR Assay with Single-Copy Sensitivity for Human Immunodeficiency Virus Type 1 RNA in Plasma

  2003cited by this paper
• Longitudinal monitoring of 2-long terminal repeat circles in peripheral blood mononuclear cells from patients with chronic HIV-1 infection

  2003cited by this paper
• Intrinsic Stability of Episomal Circles Formed during Human Immunodeficiency Virus Type 1 Replication

  2002cited by this paper
• Virological and immunological effects of short-course antiretroviral therapy in primary HIV infection

  2002cited by this paper
• Short-term exercise training improves body composition and hyperlipidaemia in HIV-positive individuals with lipodystrophy.

  2001cited by this paper
• Seymour S. Kety 1915–2000

  2000cited by this paper
• Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

  1999cited by this paper
• Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin

  1998cited by this paper
• Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection.

  1998cited by this paper
• Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

  1997cited by this paper
• Prevalence of HIV, hepatitis B and associated risk behaviours in clients of a needle‐exchange in central London

  1991cited by this paper

• Long-term effect of temporary ART initiated during primary HIV-1 infection on viral persistence

  2025cites this paper
• CD4-mimetics sensitize HIV-infected cells to ADCC mediated by plasma from persons with early-stage HIV-1 infection

  2025cites this paper
• The Value of Myocardial Energy Expenditure in the Diagnosis of Cirrhotic Cardiomyopathy

  2025influential citation
• HIV-1 proviral DNA in purified peripheral blood CD34+ stem and progenitor cells in individuals with long-term HAART; paving the way to HIV gene therapy

  2024cites this paper
• Assessing advances in three decades of clinical antiretroviral therapy on the HIV-1 reservoir

  2024cites this paper
• Impact of antiretroviral therapy during acute or early HIV infection on virologic and immunologic outcomes: results from a multinational clinical trial

  2024cites this paper
• Long-term effects of early antiretroviral initiation on HIV reservoir markers: a longitudinal analysis of the MERLIN clinical study

  2021cites this paper
• HIV-1 viral blips are associated with repeated and increasingly high levels of cell-associated HIV-1 RNA transcriptional activity

  2021cites this paper
• Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection

  2021cites this paper
• Alteration in Oral Microbiome Among Men Who Have Sex With Men With Acute and Chronic HIV Infection on Antiretroviral Therapy

  2021cites this paper
• Cd4+ T Cell Recovery And Cerebrospinal Fluid Escape After Antiretroviral Therapy Initiation In Acute Hiv-1 Infection

  2020cites this paper
• Initiation of Antiretroviral Therapy during Primary HIV Infection: Effects on the Latent HIV Reservoir, Including on Analytic Treatment Interruptions.

  2020cites this paper
• Harnessing CD8+ T Cells Under HIV Antiretroviral Therapy

  2019cites this paper
• HIV-1 DNA Is Maintained in Antigen-Specific CD4+ T Cell Subsets in Patients on Long-Term Antiretroviral Therapy Regardless of Recurrent Antigen Exposure

  2019cites this paper
• Immune Activations and Viral Tissue Compartmentalization During Progressive HIV-1 Infection of Humanized Mice

  2019cites this paper
• Mass cytometry identifies distinct CD4+ T cell clusters distinguishing HIV-1-infected patients according to antiretroviral therapy initiation.

  2019cites this paper
• Therapeutic Vaccination Refocuses T-cell Responses Towards Conserved Regions of HIV-1 in Early Treated Individuals (BCN 01 study)

  2019cites this paper
• Beyond one pill, once daily: current challenges of antiretroviral therapy management in the United States

  2019cites this paper
• HIV-1 Elimination in Humanized Mice

  2019cites this paper
• CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNA

  2018cites this paper
• Viral Loads Within 6 Weeks After Diagnosis of HIV Infection in Early and Later Stages: Observational Study Using National Surveillance Data

  2018cites this paper
• Myeloid Dendritic Cells Induce HIV Latency in Proliferating CD4+ T Cells

  2018cites this paper
• High decay of blood HIV reservoir when tenofovir/emtricitabine/elvitegravir/cobicistat is initiated during the acute primary HIV infection

  2017cites this paper
• HIV dynamics linked to memory CD4+ T cell homeostasis

  2017cites this paper
• Early Antiretroviral Therapy Is Associated with Lower HIV DNA Molecular Diversity and Lower Inflammation in Cerebrospinal Fluid but Does Not Prevent the Establishment of Compartmentalized HIV DNA Populations

  2017cites this paper
• Post-treatment control or treated controllers? Viral remission in treated and untreated primary HIV infection

  2017cites this paper
• Optimal control therapy and vaccination for special HIV-1 model with delay

  2016cites this paper
• Immune activation during acute HIV infection and the impact of early antiretroviral therapy

  2016cites this paper
• Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy

  2016cites this paper
• CD4+ T Follicular Helper and IgA+ B Cell Numbers in Gut Biopsies from HIV-Infected Subjects on Antiretroviral Therapy Are Similar to HIV-Uninfected Individuals

  2016cites this paper
• Title Early Antiretroviral Therapy Is Associated with Lower HIV DNA Molecular Diversity and Lower Inflammation in Cerebrospinal Fluid but Does Not Prevent the Establishment of Compartmentalized HIV DNA Populations Permalink

  2016cites this paper
• Achieving HIV-1 Control through RNA-Directed Gene Regulation

  2016cites this paper
• Major influence of CD4 count at the initiation of cART on viral and immunological reservoir constitution in HIV-1 infected patients

  2016cites this paper
• Impact of early cART in the gut during acute HIV infection.

  2016cites this paper
• Immune activation and immune aging in HIV infection

  2016cites this paper
• Monitoring Integration over Time Supports a Role for Cytotoxic T Lymphocytes and Ongoing Replication as Determinants of Reservoir Size

  2016cites this paper
• HIV‐1 DNA dynamics and variations in HIV‐1 DNA protease and reverse transcriptase sequences in multidrug‐resistant patients during successful raltegravir‐based therapy

  2016cites this paper
• Markers of HIV reservoir size and immune activation after treatment in acute HIV infection with and without raltegravir and maraviroc intensification

  2015cites this paper